(Q45158260)

10 December 2017

Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. (English)

1 reference

10 December 2017

1 reference

J R van Beijnum

1

1 reference

10 December 2017

P Nowak-Sliwinska

2

1 reference

10 December 2017

E van den Boezem

3

1 reference

10 December 2017

P Hautvast

4

1 reference

10 December 2017

W A Buurman

5

1 reference

10 December 2017

A W Griffioen

6

1 reference

10 December 2017

language of work or name

English

0 references

publication date

5 March 2012

1 reference

10 December 2017

1 reference

10 December 2017

32

1 reference

10 December 2017

3

1 reference

10 December 2017

363-374

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.49

10 December 2017

0 references

cites work

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Isolation of endothelial cells from fresh tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Specific recognition of cruciform DNA by nuclear protein HMG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

High-mobility group box 1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

High mobility group 1 B-box mediates activation of human endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Accessing key steps of human tumor progression in vivo by using an avian embryo model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

HMGB1 interacts differentially with members of the Rel family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Role of HMGB1 in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Organometallic ruthenium(II) arene compounds with antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Spheroid-based human endothelial cell microvessel formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Angiogenesis gene expression profiling in xenograft models to study cellular interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High-Mobility Group Box Chromosomal Protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Inhibition of tumor angiogenesis by HMGB1 A box peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.49

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.49

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference